z-logo
Premium
NIR‐II Photoacoustic Reporter for Biopsy‐Free and Real‐Time Assessment of Wilson's Disease
Author(s) -
Fu Qinrui,
Ye Jiamin,
Wang Juejun,
Liao Naishun,
Feng Hongjuan,
Su Lichao,
Ge Xiaoguang,
Yang Huanghao,
Song Jibin
Publication year - 2021
Publication title -
small
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.785
H-Index - 236
eISSN - 1613-6829
pISSN - 1613-6810
DOI - 10.1002/smll.202008061
Subject(s) - nanoprobe , biopsy , in vivo , photoacoustic imaging in biomedicine , detection limit , liver biopsy , nanorod , materials science , biodistribution , biomedical engineering , nanotechnology , chemistry , pathology , medicine , nanoparticle , biology , chromatography , optics , physics , microbiology and biotechnology
Wilson's disease (WD) is a rare inherited disorder of copper metabolism with pathological copper hyperaccumulation in some vital organs. However, the clinical diagnosis technique of WD is complicated, aggressive, and time‐consuming. In this work, a novel ratiometric photoacoustic (PA) imaging nanoprobe in the NIR‐II window is developed to achieve noninvasive, rapid, and accurate Cu 2+ quantitative detection in vitro and in vivo. The nanoprobe consists of Cu 2+ ‐responsive IR970 dye and a nonresponsive palladium‐coated gold nanorod (AuNR‐Pd), achieving a concentration‐dependent ratiometric PA 970 /PA 1260 signal change. The urinary Cu 2+ content is detectable within minutes down to a detection limit of 76 × 10 −9 m . This report acquisition time is several orders of magnitude shorter than those of existing detection approaches requiring complex procedure. Moreover, utilizing the ratiometric PA nanoprobe, PA imaging enables biopsy‐free measurement of the liver Cu 2+ content and visualization of the liver Cu 2+ biodistribution of WD patient, which avoid the body injury during the clinical Cu 2+ test using liver biopsy method. The NIR‐II ratiometric PA detection method is simple and noninvasive with super precision, celerity, and simplification, which holds great promise as an alternative to liver biopsy for clinical diagnosis of WD.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here